Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flows (Unaudited)

v3.5.0.2
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
6 Months Ended
Jun. 30, 2016
Jun. 30, 2015
Cash flows from operating activities:    
Net loss $ (12,411,000) $ (2,542,000)
Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent (431,000) (936,000)
Loss from continuing operations, net of taxes (11,980,000) (1,606,000)
Adjustments to reconcile loss from continuing operations to cash used in operating activities:    
Depreciation and amortization 1,796,000 1,909,000
Amortization of debt discount 43,000 43,000
Deferred tax (benefit) expense (3,130,000) 71,000
Recovery of bad debt reserves (351,000) (21,000)
Loss on disposal of property and equipment 4,000
Impairment loss on tangible assets 1,816,000
Impairment loss on intangible assets 8,288,000
Issuance of common stock for services 116,000 140,000
Stock-based compensation 45,000 46,000
Changes in operating assets and liabilities of continuing operations    
Restricted cash 35,000
Accounts receivable (189,000) (1,322,000)
Unbilled receivables 1,186,000 1,332,000
Prepaid expenses, inventories and other assets 1,831,000 451,000
Accounts payable, accrued expenses and unearned revenue (1,041,000) (2,316,000)
Cash used in continuing operations (1,531,000) (1,273,000)
Cash used in discontinued operations (458,000) (798,000)
Cash used in operating activities (1,989,000) (2,071,000)
Cash flows from investing activities:    
Purchases of property and equipment (28,000) (265,000)
Proceeds from sale of property and equipment 2,000
Payment to finite risk sinking fund (45,000) (17,000)
Cash used in investing activities of continuing operations (71,000) (282,000)
Proceeds from sale of property of discontinued operations 46,000
Cash used in investing activities (25,000) (282,000)
Cash flows from financing activities:    
Repayments of revolving credit borrowings (26,594,000) (31,478,000)
Borrowing of revolving credit 29,131,000 33,162,000
Proceeds from Issuance of common stock 7,000
Release of proceeds for stock subscription for Perma-Fix Medical S.A. previously held in escrow 64,000
Principal repayments of long term debt (889,000) (1,164,000)
Principal repayments of long term debt-related party (750,000) (750,000)
Cash provided by (used in) financing activities of continuing operations 962,000 (223,000)
Effect of exchange rate changes on cash (4,000) (63,000)
Decrease in cash (1,056,000) (2,639,000)
Cash at beginning of period 1,435,000 3,680,000
Cash at end of period 379,000 1,041,000
Supplemental disclosure:    
Interest paid 204,000 277,000
Income taxes paid $ 25,000 $ 50,000